Arrowhead Pharmaceuticals In call shares owned by Group One Trading
Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In call shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Arrowhead Pharmaceuticals In call
Tip: Access up to 7 years of quarterly data
All positions including Arrowhead Pharmaceuticals In call held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrowhead Pharmaceuticals In call by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.4M | 40k | 34.49 |
| 2025-06-30 | $662k | 42k | 15.80 |
| 2025-03-31 | $373k | 29k | 12.74 |
| 2024-12-31 | $519k | 28k | 18.80 |
| 2024-09-30 | $9.7k | 500 | 19.37 |
| 2024-06-30 | $88k | 3.4k | 25.99 |
| 2024-03-31 | $927k | 32k | 28.60 |
| 2023-09-30 | $1.4M | 52k | 26.87 |
| 2023-06-30 | $2.2M | 61k | 35.66 |
| 2023-03-31 | $1.0M | 41k | 25.40 |
| 2022-12-31 | $3.6M | 90k | 40.56 |
| 2022-09-30 | $2.6M | 79k | 33.05 |
| 2022-06-30 | $2.2M | 63k | 35.21 |
| 2022-03-31 | $4.9M | 108k | 45.99 |
| 2021-12-31 | $9.1M | 137k | 66.30 |
| 2021-09-30 | $8.4M | 134k | 62.43 |
| 2021-06-30 | $10M | 125k | 82.82 |
| 2021-03-31 | $6.1M | 92k | 66.31 |
| 2020-12-31 | $22M | 292k | 76.73 |
| 2020-09-30 | $3.4M | 80k | 43.05 |
| 2020-06-30 | $7.3M | 168k | 43.19 |
| 2020-03-31 | $3.6M | 124k | 28.77 |
| 2019-12-31 | $7.6M | 120k | 63.43 |
| 2019-09-30 | $1.8M | 63k | 28.17 |
| 2019-06-30 | $2.6M | 98k | 26.50 |
| 2019-03-31 | $242k | 13k | 18.33 |
| 2018-12-31 | $647k | 52k | 12.42 |
| 2018-09-30 | $3.8M | 197k | 19.17 |
| 2018-06-30 | $2.5M | 184k | 13.60 |
| 2018-03-31 | $515k | 71k | 7.21 |
| 2017-12-31 | $793k | 216k | 3.68 |
| 2017-09-30 | $989k | 228k | 4.33 |
| 2017-03-31 | $202k | 109k | 1.85 |
| 2016-12-31 | $145k | 94k | 1.55 |
| 2016-09-30 | $823k | 112k | 7.35 |
| 2016-06-30 | $301k | 57k | 5.32 |
Top funds holding Arrowhead Pharmaceuticals In call
View all funds holding Arrowhead Pharmaceuticals In call